LSD1 Antibody Market Overview
The LSD1 Antibody Market is experiencing robust growth driven by expanding applications in cancer research and epigenetic studies. Valued at USD 1.0 billion in 2024, this market is projected to reach USD 2.5 billion by 2035, reflecting a compound annual growth rate of 8.3%. LSD1 (Lysine-Specific Demethylase 1) antibodies serve as essential tools for detecting histone demethylation patterns...
0 Comments 0 Shares 10 Views 0 Reviews